Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹54,050Qualified Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: ISOZI 300 2 OFFICE NO 2B II CITI MALL BUILDING NO 03 LINK ROAD ANDHERI WEST MUMBAI SUBURBAN MAHARASTRA MUMBAI MAHARASHTRA 400053 | MUMBAI SUBURBAN | MAHARASHTRA | 400053 | Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: ISOZI 300 | L1 | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
7 Jul 2023, 6:00 pmClosed
Anti TB Drugs - Isoniazid 300 mg Tablet (Q1)
4957159
GEM/2023/B/3623226
Two Packet Bid
Anti TB Drugs - Isoniazid 300 mg Tablet
GeM Contract
45 days
Karnataka; Haveri
Total value wise evaluation
PRODUCT
Awarded to HEALTHY LIFE PHARMA PRIVATE LIMITED
₹54,050
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED Isoniazid 300 mg Tablet | Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED / ISOZI 300 | 3004 | 5,000 strip | 10.81 | 54,050 |
4 documents required · 4 mandatory
1 yrs
₹3
10%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Anti TB Drugs - Isoniazid 300 mg Tablet (Q1) | Neelesh MN 581110,#16,1 ST FLOOR, B BLOCK, D.C.COMPLEX, HAVERI | 5,000 | 45 days |
Exempted
21 Jul 2023
27 Jun 2023
7 Jul 2023
contract_GEMC-511687738082243.pdf
GEM_CONTRACT • 0.08 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_4957159.pdf
GEM_BID
isoniazid-300mg-pc-11-updated-feb-2021_2022-04-13-12-48-05_eeb1caa0dee44e836051b46bc7819ed1.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .